Literature DB >> 23076875

The scavenger endothelial cell: a new player in homeostasis and immunity.

Karen Kristine Sørensen1, Peter McCourt, Trond Berg, Clive Crossley, David Le Couteur, Kenjiro Wake, Bård Smedsrød.   

Abstract

To maintain homeostasis, the animal body is equipped with a powerful system to remove circulating waste. This review presents evidence that the scavenger endothelial cell (SEC) is responsible for the clearance of blood-borne waste macromolecules in vertebrates. SECs express pattern-recognition endocytosis receptors (mannose and scavenger receptors), and in mammals, the endocytic Fc gamma-receptor IIb2. This cell type has an endocytic machinery capable of super-efficient uptake and degradation of physiological and foreign waste material, including all major classes of biological macromolecules. In terrestrial vertebrates, most SECs line the wall of the liver sinusoid. In phylogenetically older vertebrates, SECs reside instead in heart, kidney, or gills. SECs, thus, by virtue of their efficient nonphagocytic elimination of physiological and microbial substances, play a critical role in the innate immunity of vertebrates. In major invertebrate phyla, including insects, the same function is carried out by nephrocytes. The concept of a dual-cell principle of waste clearance is introduced to emphasize that professional phagocytes (macrophages in vertebrates; hemocytes in invertebrates) eliminate larger particles (>0.5 μm) by phagocytosis, whereas soluble macromolecules and smaller particles are eliminated efficiently and preferentially by clathrin-mediated endocytosis in nonphagocytic SECs in vertebrates or nephrocytes in invertebrates. Including these cells as important players in immunology and physiology provides an additional basis for understanding host defense and tissue homeostasis.

Mesh:

Substances:

Year:  2012        PMID: 23076875     DOI: 10.1152/ajpregu.00686.2011

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  65 in total

1.  Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model.

Authors:  Qi Liu; Xiang Wang; Xiangsheng Liu; Sanjan Kumar; Grant Gochman; Ying Ji; Yu-Pei Liao; Chong Hyun Chang; Wesley Situ; Jianqin Lu; Jinhong Jiang; Kuo-Ching Mei; Huan Meng; Tian Xia; Andre E Nel
Journal:  ACS Nano       Date:  2019-04-12       Impact factor: 15.881

2.  Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia.

Authors:  Colin D Godwin; George B McDonald; Roland B Walter
Journal:  Blood       Date:  2017-02-02       Impact factor: 22.113

Review 3.  Therapeutic targeting of liver inflammation and fibrosis by nanomedicine.

Authors:  Matthias Bartneck; Klaudia Theresa Warzecha; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 4.  Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications.

Authors:  Lily Dara; Zhang-Xu Liu; Neil Kaplowitz
Journal:  Liver Int       Date:  2015-11-11       Impact factor: 5.828

Review 5.  Liver Sinusoidal Endothelial Cell: An Update.

Authors:  Laurie D DeLeve; Ana C Maretti-Mira
Journal:  Semin Liver Dis       Date:  2017-12-22       Impact factor: 6.115

6.  Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeys.

Authors:  Amita Datta-Mannan; Johnny E Croy; Linda Schirtzinger; Stacy Torgerson; Matthew Breyer; Victor J Wroblewski
Journal:  MAbs       Date:  2016-07       Impact factor: 5.857

Review 7.  Dietary and metabolic modulators of hepatic immunity.

Authors:  Antonella Carambia; Johannes Herkel
Journal:  Semin Immunopathol       Date:  2017-11-06       Impact factor: 9.623

Review 8.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

9.  Effects of intravitreally injected Fc fragment on rat eyes.

Authors:  Tatjana Taubitz; Laura-Pia Steinbrenner; Alexander V Tschulakow; Antje Biesemeier; Sylvie Julien-Schraermeyer; Ulrich Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-17       Impact factor: 3.117

10.  Hepatic disposal of advanced glycation end products during maturation and aging.

Authors:  Dmitri Svistounov; Ana Oteiza; Svetlana N Zykova; Karen Kristine Sørensen; Peter McCourt; Andrew J McLachlan; Robert S McCuskey; Bård Smedsrød
Journal:  Exp Gerontol       Date:  2013-03-24       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.